BriaCell Therapeutics (BCT.TO, BCTX) was last seen up 5.5% in after-hours Nasdaq trading after the company on Tuesday the closing of its best-efforts share offering that raised $4.7 million.
The company placed 1.45-million shares priced at $3.25 each in the offer..
The company intends to use proceeds from the offering for working capital requirements, general corporate purposes, and the advancement of business objectives.
BrieCell shares were up US$0.18 at last look to US$3.45, after closing down C$0.05 to C$4.51 on Toronto Stock Exchange.